RISA J LAVIZZO-MOUREY
CIK 1034465 · last filed 2026-06-02
RISA J LAVIZZO-MOUREY is a corporate insider who has filed 89 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for MRK, was dated Jun 2, 2026. Across all open-market trades the lifetime net is +$612.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.5M across reported positions. 25 SEC filings were submitted jointly with ELECTRIC CO GENERAL.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.53M
9
89
$612.1K
Filer Profile
500 W. MONROE ST.
CHICAGO, IL 60661
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRK | Director | 1,000 | $150.33 | $150.3K | $0 | 7 | 2026-06-02 |
| GEHC | Director | 10,157 | $68.86 | $699.4K | $0 | 3 | 2025-05-30 |
| INTC | Director | 29,772 | $95.80 | $2.85M | $247.5K | 13 | 2024-05-10 |
| Better Therapeutics, Inc. (BTTX) Delisted | Director | 13,750 | $0.04 | $613 | $46.0K | 5 | 2023-12-20 |
| GE | Director | 5,016 | $337.12 | $1.69M | $97.5K | 24 | 2023-01-05 |
| GE HealthCare Technologies Inc. (GEHCV) Delisted | Director | 1,041 | — | — | $0 | 1 | 2023-01-05 |
| HESS CORP (HES) Delisted | Director | 44,379 | $160.40 | $7.12M | $175.1K | 14 | 2020-03-10 |
| GNW | Director | 13,000 | $10.35 | $134.6K | $46.0K | 17 | 2012-04-02 |
| BECKMAN COULTER INC (BEC) Delisted | Director | 2,100 | — | — | $0 | 5 | 2007-07-06 |
Recent Filings
89 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | MRK | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | MRK | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | GEHC | Grant (A) | +3,092 | $0 | EDGAR |
| 2024-06-04 | MRK | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | GEHC | Grant (A) | +2,440 | $0 | EDGAR |
| 2024-05-10 | INTC | Grant (A) | — | $0 | EDGAR |
| 2024-05-09 | INTC | Exer (M) | +7,152 | $0 | EDGAR |
| 2023-12-20 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | +3,750 | $0 | EDGAR |
| 2023-06-09 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-31 | MRK | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.